RecommendationsA
Matt Taibbi's "Wall Street's Naked Swindle," which ran in the October 15 issue of Rolling Stone magazine, is a terrific expose of the corruption at the highest levels. Briefly, it appears that, back in March 2008, someone who attended the closed-door meeting among Treasury officials, the Fed and certain anointed big banks immediately bought $1.7 million dollars of put options on Bear Stearns stock, then trading at $63, with strike prices 50 and 60 percent lower and which were due to expire in nine days. Bear Stearns stock crashed when it became clear that the Fed and the Treasury, contrary to its policy with other, favored banks, would not support the company. Its stock crashed, and within six days, the put position was worth $270 million, netting the put buyer 159 times his money on "insider information" at the highest level. A lawyer formerly serving as senior counsel for the SEC expressed dismay that the SEC has somehow been unable to follow the money trail: "I've seen the SEC send agents overseas in a simple insider-trading case to investigate profits of maybe $2,000." Taibbi didn't say it, but everyday bureaucratic incompetence can hardly explain the SEC's inability to track down this person after nearly two years, nor the lack of insistence by the Senate Banking Committee, Congress or any other governing body that the trail be followed and the culprit be caught. Influence of powerful people in government, however, would explain it just fine. You can read the article at http://www.rollingstone.com/politics/story/30481512/wall streets naked swindle.
Thursday, November 19, 2009
Criminals among us
The folks at Elliott Wave International have been solid advertisers and partners with this blog for several years now. I try to respect their intellectual property rights out of a strong sense of loyalty and ethics, but today, I will stretch the concept of fair use a bit with a verbatim quote from today's Elliott Wave Theorist. I think the nature and importance of what follows sufficiently explains my motivation and hopefully will excuse my momentary departure from an otherwise strict adherence to respecting their proprietary content.
They're off
Needless to say, all intraday time frames are solidly LONG now for TZA. Next target, the Daily Buy @ 12.68.
A
Wednesday, November 18, 2009
Off to the races?
These are 240 minute charts of TZA and the RUT on which it is based. This is the longest intraday period I find useful, as the next useful period is the Daily chart. With two hours left before the close of trading, I would pay close attention to these two charts triggering new signals going into the close. In other words, if the 240 TZA flips LONG (>11.80) and/or the RUT flips SHORT (<593.63), markets may be very well be off to the races on the downside.
A
NNVC - heads up
Wednesday and Thursday hold the potential to be news days for NNVC, as both Dr. Diwan (President) and Dr. Seymour (CEO) will be featured speakers at separate conferences. There is always a chance that something one or both of them have to say about ongoing research will ring the bell in a market moving way.
Wednesday:
3.30 p.m. – 5.00 p.m.
Session IV – The Intersection of Nanotechnology and Biology
Session Chair and Moderator – Jim Hurd, Director, NanoScience Exchange, San Francisco, CA
Prof. Brij Moudgil, Distinguished Professor and Alumni Professor of Materials Science and Engineering,
and Director of Particle Engineering Research Center, University of Florida, Gainesville, FL
Dr. Anil Diwan, President and Chairman, NanoViricides, Inc., West haven, CT,
"Nanoviricides - Novel Antiviral Agents Against HIV, Influenza, and Many Other
Diseases"
• What is a nanoviricide : "Find-Encapsulate-Destroy" antiviral strategy
• FluCide(tm) - Pan-Influenza nanoviricide against pandemic, epidemic influenzas, bird flu,
high path viruses
• HivCide(tm) - Anti-HIV nanoviricide was superior to oral HAART cocktail therapy in
animal models
• Broad-spectrum nanoviricides - A low cost approach against Neglected Tropical Diseases
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43688654
Thursday:
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide Studies at the Influenza Congress 2009
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment.
Dr. Seymour will review the Company’s recent in vivo studies against influenza. The success of these studies has led the Company to consolidate its anti-influenza drug programs into a single, pan-influenza drug, “FluCide™”. This single drug is expected to be highly effective against all forms of influenza A, including the recent “swine flu” 2009/CA/H1N1 strain, seasonal flu strains, as well as H5N1 bird flu strains feared to be capable of creating a devastating pandemic, and other highly pathogenic strains on the horizon.
A “pan-influenza” drug is widely sought in order to enable treating infections from novel influenza viruses. It is well known that pandemics can be caused by novel strains of influenza. Fortunately the current “swine flu” H1N1/2009 pandemic is now believed to cause fatality rates comparable to seasonal influenzas. However, influenza viruses are known to change rapidly. New influenza viruses are often generated by mixing of genetic material from existing influenza viruses, known as “reassortments”. Such changes can lead to a novel virus that is capable of causing a wide-spread pandemic accompanied by a high fatality rate. In addition, mutations are known to have led to influenza strains resistant to existing anti-influenza drugs. The Company believes that FluCide is designed to minimize the possibility of resistant mutations.
http://finance.yahoo.com/news/NanoViricides-Inc-to-Present-bw-755360621.html?x=0&.v=1
A
Wednesday:
3.30 p.m. – 5.00 p.m.
Session IV – The Intersection of Nanotechnology and Biology
Session Chair and Moderator – Jim Hurd, Director, NanoScience Exchange, San Francisco, CA
Prof. Brij Moudgil, Distinguished Professor and Alumni Professor of Materials Science and Engineering,
and Director of Particle Engineering Research Center, University of Florida, Gainesville, FL
Dr. Anil Diwan, President and Chairman, NanoViricides, Inc., West haven, CT,
"Nanoviricides - Novel Antiviral Agents Against HIV, Influenza, and Many Other
Diseases"
• What is a nanoviricide : "Find-Encapsulate-Destroy" antiviral strategy
• FluCide(tm) - Pan-Influenza nanoviricide against pandemic, epidemic influenzas, bird flu,
high path viruses
• HivCide(tm) - Anti-HIV nanoviricide was superior to oral HAART cocktail therapy in
animal models
• Broad-spectrum nanoviricides - A low cost approach against Neglected Tropical Diseases
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43688654
Thursday:
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide Studies at the Influenza Congress 2009
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment.
Dr. Seymour will review the Company’s recent in vivo studies against influenza. The success of these studies has led the Company to consolidate its anti-influenza drug programs into a single, pan-influenza drug, “FluCide™”. This single drug is expected to be highly effective against all forms of influenza A, including the recent “swine flu” 2009/CA/H1N1 strain, seasonal flu strains, as well as H5N1 bird flu strains feared to be capable of creating a devastating pandemic, and other highly pathogenic strains on the horizon.
A “pan-influenza” drug is widely sought in order to enable treating infections from novel influenza viruses. It is well known that pandemics can be caused by novel strains of influenza. Fortunately the current “swine flu” H1N1/2009 pandemic is now believed to cause fatality rates comparable to seasonal influenzas. However, influenza viruses are known to change rapidly. New influenza viruses are often generated by mixing of genetic material from existing influenza viruses, known as “reassortments”. Such changes can lead to a novel virus that is capable of causing a wide-spread pandemic accompanied by a high fatality rate. In addition, mutations are known to have led to influenza strains resistant to existing anti-influenza drugs. The Company believes that FluCide is designed to minimize the possibility of resistant mutations.
http://finance.yahoo.com/news/NanoViricides-Inc-to-Present-bw-755360621.html?x=0&.v=1
Tuesday, November 17, 2009
Parallax view
Below the Russell, TZA and SPX from 13, 30 and 13 minute views, respectively:
Clarification of trend
Clarification of trend
Monday, November 16, 2009
Notes
Below is the Weekly chart of the Russell 2000 Index.
Note the Wave 5 Sell Signal. Note the FBS Sell Signal. Note the ATR Sell Signal. Note the target drop, 50% from current levels. Note that we are trading the 3X leveraged bear etf of this index, TZA. Note that unless this index reverses and triggers a Weekly Buy Signal, the main trend is down and TZA-friendly.
Note that we have been blown out of the water time and time again shorting this market. Note that it takes balls of steel to keep on shorting. Note that the definition of insanity to to repeat the same behavior time after time with the expectation of a different outcome. Note that Freud found a sexual context underlying all human behavior. Note that I have just injected sex into my analysis and it actually made sense.........until I pointed it out to you. Note that I am going to bed now.
Nighty night.
A
Note the Wave 5 Sell Signal. Note the FBS Sell Signal. Note the ATR Sell Signal. Note the target drop, 50% from current levels. Note that we are trading the 3X leveraged bear etf of this index, TZA. Note that unless this index reverses and triggers a Weekly Buy Signal, the main trend is down and TZA-friendly.
Note that we have been blown out of the water time and time again shorting this market. Note that it takes balls of steel to keep on shorting. Note that the definition of insanity to to repeat the same behavior time after time with the expectation of a different outcome. Note that Freud found a sexual context underlying all human behavior. Note that I have just injected sex into my analysis and it actually made sense.........until I pointed it out to you. Note that I am going to bed now.
Nighty night.
A
Subscribe to:
Posts (Atom)